Haoxi Health Technology Limited Launches Customized Livestreaming Agency Strategy
MWN-AI** Summary
Haoxi Health Technology Limited, a Beijing-based online marketing solution provider, has recently launched a customized livestreaming agency strategy through its subsidiary, Beijing Haoxi Digital Technology Co., Ltd. This strategic initiative aims to cater to the growing demand for personalized and high-quality marketing services within the medical aesthetics sector. Given the recent surge in interest in “light medical aesthetics,” such as laser and injection-based treatments, Haoxi Beijing is evolving the marketing landscape by integrating consumer trends with platform-specific operational strategies.
The new livestreaming service offers a comprehensive approach that encompasses pre-campaign planning, livestream execution, and post-campaign analysis. This full-cycle approach aims to enhance client engagement and improve online conversion rates while supporting long-term brand development. Mr. Zhen Fan, Chairman and CEO of Haoxi, emphasized that the launch reflects the company's mission to provide innovative marketing solutions specifically tailored for the healthcare sector.
Haoxi Health Technology’s foray into customized livestreaming reinforces its commitment to delivering cutting-edge marketing offerings. The service includes account setup, content planning, short video marketing, and platform resource integration. As part of this initiative, ongoing discussions are in progress with several long-term clients from the medical aesthetics field, positioning Haoxi as a leader in customized livestreaming solutions.
With an established reputation from its advertising delivery model and a focus on enhancing efficiency within the healthcare advertising sector, Haoxi continues to evolve alongside market dynamics. The company aims to reduce costs and streamline online marketing for healthcare advertisers, leveraging popular platforms in China such as WeChat and Douyin. This represents a notable evolution in Haoxi's business development roadmap and opens avenues for sustained growth in the rapidly expanding healthcare market.
MWN-AI** Analysis
Haoxi Health Technology Limited's recent launch of a customized livestreaming agency strategy presents a significant opportunity for investors, especially within the healthcare and medical aesthetics sectors. This innovative approach taps into the increasing consumer demand for personalized, high-quality services, particularly in a landscape where digital marketing is rapidly evolving.
The company's strategy is underpinned by its established experience in online marketing, particularly through news feed ads, which have been a cornerstone of its operations. By offering a comprehensive suite of services—from account setup and content planning to post-campaign analysis—Haoxi Beijing is poised to improve online conversion rates for its clients, thereby enhancing long-term brand loyalty.
As the Chinese healthcare sector continues to expand, propelled by rising disposable incomes and a shift towards beauty and wellness, Haoxi's focus on ‘light medical aesthetics’ will likely resonate well with consumers. This segment's growth offers a promising revenue stream, allowing Haoxi to drive additional value through tailored livestreaming services.
Investors should also consider the potential for partnership developments that Haoxi is pursuing, which could solidify its market position and create synergies within the industry. However, it’s crucial to remain cognizant of the risks outlined in the company's forward-looking statements, including market condition uncertainties that could affect performance.
Overall, Haoxi Health Technology Limited's strategic initiative could position it well within a lucrative market, making it an attractive option for investors looking to capitalize on trends in digital marketing and healthcare. Given these factors, careful monitoring of Haoxi's performance and market dynamics will be essential for making informed investment decisions moving forward.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
BEIJING, April 21, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, announced that Beijing Haoxi Digital Technology Co., Ltd. (“Haoxi Beijing”), a wholly-owned subsidiary of the Company, has launched its customized livestreaming agency strategy and is progressing partnership discussions on personalized livestreaming agency services with several long-term clients of medical aesthetics, marking a new strategic step in the Company’s business development roadmap.
Driven by the growing demand for personalized and high-quality services in the healthcare and medical aesthetics sectors, and in response to evolving macro-consumption trends, Haoxi Beijing has officially launched its livestreaming agency services. This offering comes after the Company’s successful establishment of a stable advertising delivery model built on long-term client servicing experience. The new service covers a full-cycle, closed-loop approach—from pre-campaign planning and livestream initiation to post-campaign analysis—tailored especially for the booming “light medical aesthetics” segment, including laser and injection-based treatments. It is designed to integrate evolving consumer behaviors with platform-specific operational strategies.
Mr. Zhen Fan, Chairman and CEO of Haoxi Health Technology Limited, commented: “Our foray into customized livestreaming services is a natural extension of HAO’s mission to offer precise, efficient, and innovative marketing solutions to the healthcare sector.
“The launch of the customized livestreaming agency strategy marks a key milestone in HAO’s expansion into customized livestreaming marketing solutions. Within the partnership framework under discussion, Haoxi Beijing will provide clients with a comprehensive suite of services, including account setup, content planning, short video marketing, livestream ad strategy, and platform resource integration—all aimed at supporting long-term brand building and improving online conversion rates.”
About Haoxi Health Technology Limited
Haoxi Health Technology Limited is a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients. The Company’s growth is driven by the rise of news feed ads and the rapid development of the healthcare sector. The Company offers one-stop online marketing solutions, especially in online short video marketing, helping advertisers acquire and retain customers on popular platforms in China, such as Toutiao, Douyin, WeChat, and Sina Weibo. It is dedicated to reducing costs, increasing efficiency, and providing easy online marketing solutions to advertisers. For more information, please visit: http://ir.haoximedia.com.
Forward-Looking Statement
This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
For more information, please contact:
Investor Relations
WFS Investor Relations Inc.
Janice Wang, Managing Partner
Email: services@wealthfsllc.com
Phone: +86 13811768599
+1 628 283 9214
FAQ**
How does Haoxi Health Technology Limited plan to leverage its partnership discussions with long-term clients in the medical aesthetics sector while remaining aligned with the objectives of Invesco China Small Cap ETF Invesco Capital Management LLC HAO?
What strategies will Haoxi Beijing employ to differentiate its customized livestreaming agency services from competitors in the rapidly developing healthcare marketing sector, especially in relation to Invesco China Small Cap ETF Invesco Capital Management LLC HAO?
Can Haoxi Health Technology Limited provide insights into the expected impact of its full-cycle livestreaming services on its overall revenue growth, particularly concerning the investment strategies of Invesco China Small Cap ETF Invesco Capital Management LLC HAO?
What specific metrics will Haoxi Health Technology Limited use to evaluate the success of its new livestreaming agency strategy and how does this align with the performance objectives of Invesco China Small Cap ETF Invesco Capital Management LLC HAO?
**MWN-AI FAQ is based on asking OpenAI questions about Invesco China Small Cap ETF Invesco Capital Management LLC (NASDAQ: HAO).
NASDAQ: HAO
HAO Trading
10.55% G/L:
$1.205 Last:
662 Volume:
$1.09 Open:
